Showing results (1-10 of 107) with videos related to
Sort By:
Pageof 11
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 17, 2003
Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acidLilly Schwieler, Sophie ErhardtSynapse (New York, N.Y.)|March 23, 2004
Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complexLilly Schwieler, Göran Engberg, Sophie ErhardtSynapse (New York, N.Y.)|February 9, 2002
Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotineSophie Erhardt, Lilly Schwieler, Göran EngbergAdvances in Experimental Medicine and Biology|June 23, 2004
Kynurenic acid and schizophreniaSophie Erhardt, Lilly Schwieler, Göran EngbergPharmacological Reviews|September 20, 2024
Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic OpportunitiesAna Pocivavsek, Robert Schwarcz, Sophie ErhardtJournal of Neuroinflammation|August 10, 2010
Acyclovir inhibition of IDO to decrease Tregs as a glioblastoma treatment adjunctJohan Söderlund, Sophie Erhardt, Richard E KastCNS Drugs|January 29, 2009
Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disordersSophie Erhardt, Sara K Olsson, Göran EngbergEuropean Journal of Clinical Nutrition|May 24, 2024
Exploring the effect of prolonged fasting on kynurenine pathway metabolites and stress markers in healthy male individualsVarvara Louvrou, Rima Solianik, Marius Brazaitis, et al.Neuropharmacology|June 2, 2016
The kynurenine pathway in schizophrenia and bipolar disorderSophie Erhardt, Lilly Schwieler, Sophie Imbeault, et al.Biological Psychiatry|August 18, 2004
Endogenous kynurenic acid disrupts prepulse inhibitionSophie Erhardt, Lilly Schwieler, Carolina Emanuelsson, et al.Pageof 11